Medical News

RSS

EKOS receives $2.7M grant to develop product for treatment of ICH

EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.

7 Jun 2010

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.

7 Jun 2010

MHRA issues Supplementary Accreditation to Chiltern

Chiltern International Limited, a global contract research organization, has announced that Chiltern Early Phase Limited, based in Ninewells Hospital and Medical School in Dundee, Scotland, has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency.

7 Jun 2010

B2Discovery rallies business leaders in support of excellence in cancer research

The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.

7 Jun 2010

Assured Pharmacy launches new website

Assured Pharmacy, a pharmacy service healthcare organization operating a chain of specialty pharmacies providing advanced prescription medication fulfillment solutions to sufferers of chronic pain, is pleased to announce the launch of its new website: www.assuredrxservices.com.

7 Jun 2010

First Edition: News coverage on Dems' health reform campaign; Medicare fees; Medical marijuana

In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Will health care reform reduce spending on health care too little? Or too much? Over the last several days, one respected authority made a version of the former argument while another made a version of the latter--offering a reminder of why reform is so complicated and why the new law, for all its imperfections, is still an important step forward" (Kaiser Health News).

7 Jun 2010

Isobionics finalizes fermentation process for production of natural Valencene Pure

Isobionics has finalized the development of a breakthrough fermentation process for production of its natural Valencene Pure. This product, which is an aroma substance for the food, beverage, flavor and fragrance industry, is now available on a commercial scale. Compared with conventional valencene, which is produced from oranges, it offers the advantage of high purity and constant quality.

7 Jun 2010

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today the full market release of its latest medical technology breakthrough—Masimo Rainbow Acoustic Monitoring— providing continuous and noninvasive respiration rate that is accurate, easy-to-use, and enhances patient tolerance.

7 Jun 2010

New GUM PerioBalance helps maintain oral health

Over 50 percent of Americans state they have moderate stress levels caused by balancing the demands of busy families and careers. However, many are unaware that stressful living, illness, poor diet or inadequate oral hygiene can disrupt your oral balance and allow bad bacteria to thrive causing plaque buildup, poor gum health and bad breath. A balanced oral environment is essential for healthy teeth and gums, just as it is for overall wellness.

7 Jun 2010

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Oslo University Hospital and Induct Software AS, "The Open Innovation Company," today announced a long term strategic partnership Agreement under which the parties will work together to help Oslo University Hospital achieve its goal of becoming the world leader in healthcare innovation.

7 Jun 2010

Parents pressure schools to comply with IDEA or face legal action regarding students with ASD

School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.

7 Jun 2010

Sentrx achieves Gold Partner status in OPN

Sentrx, a leading provider of drug safety services to the life sciences industry, has achieved Gold Partner status in the Oracle PartnerNetwork. Sentrx will provide life sciences companies with support for Oracle clinical solutions, emphasizing its expertise in drug safety systems, safety data management and adverse event reporting software, processes and consulting expertise.

7 Jun 2010

NPWT clinical hotline for patients

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc announced the launch of its Negative Pressure Wound Therapy clinical hotline for patients.

7 Jun 2010

Ten prevention tips to stay safe from infection and illness during summer camp

As summer sets in, nearly six million campers will attend summer camps in the U.S. And while summer is typically not know as cold or flu season, illnesses and injuries – some very serious – occur every year at hundreds of camps.

7 Jun 2010

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Allscripts announced today that UBMD has selected the Allscripts Electronic Health Record solution to help its 450 physicians enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

7 Jun 2010

Watermark Medical completes $15M equity investment from CA Technologies

Watermark Medical, Inc., a privately-held medical products and services company currently servicing the sleep-disordered breathing market, today announced the completion of a $15 million equity investment from CA Technologies. This equity investment in Watermark Medical represents CA Technologies' entry into the emerging Software-as-a-Service -based healthcare cloud market.

7 Jun 2010

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.

7 Jun 2010

Hospira to fund $2M loan to Javelin

Javelin Pharmaceuticals, Inc. today announced that on June 4, 2010, Javelin received notice from Hospira, Inc. that Hospira will fund a $2 million loan to Javelin on June 10, 2010 under the existing loan agreement between Javelin and Hospira.

7 Jun 2010

Immunome selected as winner of annual New York Venture Summit Top Innovator award

Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, is pleased to announce that it has been selected as a winner of the annual New York Venture Summit Top Innovator award by youngStartup Ventures. The companies awarded this honor have been identified as those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.

7 Jun 2010

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today reported preliminary outcomes and trends from the ongoing Phase III pivotal study of Generex Oral-lyn, the Company's proprietary oral insulin spray product.

7 Jun 2010

Medical News

EKOS receives $2.7M grant to develop product for treatment of ICH

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

MHRA issues Supplementary Accreditation to Chiltern

B2Discovery rallies business leaders in support of excellence in cancer research

Assured Pharmacy launches new website

First Edition: News coverage on Dems' health reform campaign; Medicare fees; Medical marijuana

Isobionics finalizes fermentation process for production of natural Valencene Pure

Masimo announces full market release of Rainbow Acoustic Monitoring to provide RRa

New GUM PerioBalance helps maintain oral health

Oslo University Hospital, Induct announce long term strategic partnership Agreement

Parents pressure schools to comply with IDEA or face legal action regarding students with ASD

Sentrx achieves Gold Partner status in OPN

NPWT clinical hotline for patients

Ten prevention tips to stay safe from infection and illness during summer camp

UBMD selects Allscripts EHR solution to help its physicians enhance quality of patient care

Watermark Medical completes $15M equity investment from CA Technologies

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

Hospira to fund $2M loan to Javelin

Immunome selected as winner of annual New York Venture Summit Top Innovator award

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News